| #157 |
Daniel M. Gauger, Jr. |
Bose |
3 |
| #157 |
Titiimaea Alailima |
Akili Interactive Labs |
3 |
| #157 |
Emil Laftchiev |
Mitsubishi Electric |
3 |
| #157 |
David J. Mooney |
Harvard University |
3 |
| #157 |
Jeffrey A. Gelfand |
The General Hospital |
3 |
| #157 |
Adam B. Fisher |
Synlogic Operating Company |
3 |
| #157 |
Alim Ladha |
MIT |
3 |
| #157 |
Jellert Gaublomme |
MIT |
3 |
| #157 |
Deep Arjun Singh |
Alcyone Lifesciences |
3 |
| #157 |
Kathleen O'Donnell |
Harvard University |
3 |
| #157 |
Ram Sasisekharan |
MIT |
3 |
| #157 |
Andrew Coats |
Portal Instruments |
3 |
| #157 |
Donald Johns |
Novartis Ag |
3 |
| #157 |
Sean Murray |
Realtime Robotics |
3 |
| #157 |
Jason D. Brubaker |
Merck |
3 |
| #157 |
Erina Ghosh |
Koniniklijke Philips N.V. |
3 |
| #157 |
Daniel McDuff |
Microsoft |
3 |
| #157 |
Eric J. VanWyk |
Deka Products Limited Parternship |
3 |
| #157 |
Nessan Bermingham |
Korro Bio |
3 |
| #157 |
Kelly R. Stevens |
MIT |
3 |
| #157 |
David A. Scott |
Arbor Biotechnologies |
3 |
| #157 |
Markus Frank |
Brigham and Women's Hospital |
3 |
| #157 |
Ruffin Evans |
Google |
3 |
| #157 |
Meng Zheng |
Shanghai United Imaging Intelligence Co. |
3 |
| #157 |
Maxim Lobovsky |
Formlabs |
3 |
| #157 |
Jie Chen |
Bristol-Myers Squibb |
3 |
| #157 |
Mordechai Perlman |
Boston Scientific Scimed |
3 |
| #157 |
Daniel Rich |
Fastcap Systems |
3 |
| #157 |
Zachary M. Thomas |
Jentek Sensors |
3 |
| #157 |
Howard Seeherman |
Pfizer |
3 |
| #157 |
Andrew Vanslette |
Ocular Therapeutix |
3 |
| #157 |
Ryan PHILIPPE |
Manus Bio |
3 |
| #157 |
Wan Fen Nicole Quah |
Google |
3 |
| #157 |
Nikhil Narsingh CHAVAN DAFLE |
MIT |
3 |
| #157 |
David J. Perreault |
MIT |
3 |
| #157 |
Rien Quirynen |
Mitsubishi Electric |
3 |
| #157 |
Timm R. Baumeister |
Genentech |
3 |
| #157 |
Keld Lundgaard |
Salesforce |
3 |
| #157 |
Suayb S. Arslan |
Quantum |
3 |
| #157 |
Cornelis Conradus Adrianus Maria Van Zon |
Koniniklijke Philips N.V. |
3 |
| #157 |
Yuanbo QIN |
Modalis Therapeutics |
3 |
| #157 |
Karl Iagnemma |
Motional Ad |
3 |
| #157 |
Thomas E. Schaus |
Harvard University |
3 |
| #157 |
Iain THOMPSON |
Modalis Therapeutics |
3 |
| #157 |
Laurie B. Schenkel |
Amgen |
3 |
| #157 |
Richard E. Olson |
Bristol-Myers Squibb |
3 |
| #157 |
Zachary Hood |
MIT |
3 |
| #157 |
Jennifer R. Downing |
Forma Therapeutics |
3 |
| #157 |
Igor Gilitschenski |
MIT |
3 |
| #157 |
Alexei Goraltchouk |
AbbVie |
3 |